Literature DB >> 24100565

Crystallization and preliminary X-ray diffraction studies of D-threo-3-hydroxyaspartate dehydratase isolated from Delftia sp. HT23.

Yu Matsumoto1, Yoshiaki Yasutake, Yuki Takeda, Tomohiro Tamura, Atsushi Yokota, Masaru Wada.   

Abstract

D-threo-3-Hydroxyaspartate dehydratase (D-THA DH) isolated from the soil bacterium Delftia sp. HT23 is a novel enzyme consisting of 380 amino-acid residues which catalyzes the conversion of D-threo-3-hydroxyaspartate to oxaloacetate and ammonia. D-THA DH also catalyzes the dehydration of L-threo-3-hydroxyaspartate, L-erythro-3-hydroxyaspartate and D-serine. The amino-acid sequence of D-THA DH shows significant similarity to that of two eukaryotic D-serine dehydratases derived from Saccharomyces cerevisiae and chicken kidney. D-THA DH is classified into the fold-type III group of pyridoxal enzymes and is the first example of a fold-type III dehydratase derived from a prokaryote. Overexpression of recombinant D-THA DH was carried out using a Rhodococcus erythropolis expression system and the obtained protein was subsequently purified and crystallized. The crystals of D-THA DH belonged to space group I4₁22, with unit-cell parameters a=b=157.3, c=157.9 Å. Single-wavelength anomalous diffraction data were collected to a resolution of 2.0 Å using synchrotron radiation at the wavelength of the Br K absorption edge.

Entities:  

Keywords:  Br-SAD; Delftia sp. HT23; alanine racemase; d-threo-3-hydroxyaspartate dehydratase; pyridoxal 5′-phosphate

Mesh:

Substances:

Year:  2013        PMID: 24100565      PMCID: PMC3792673          DOI: 10.1107/S1744309113023956

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  21 in total

Review 1.  The manifold of vitamin B6 dependent enzymes.

Authors:  G Schneider; H Käck; Y Lindqvist
Journal:  Structure       Date:  2000-01-15       Impact factor: 5.006

2.  Stereospecificity of the inhibition of L-glutamate and L-aspartate high affinity uptake in rat brain slices by threo-3-hydroxyaspartate.

Authors:  V J Balcar; G A Johnston; B Twitchin
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

3.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

4.  Characterization of LtsA from Rhodococcus erythropolis, an enzyme with glutamine amidotransferase activity.

Authors:  Yasuo Mitani; Xianying Meng; Yoichi Kamagata; Tomohiro Tamura
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

5.  Novel approach to phasing proteins: derivatization by short cryo-soaking with halides.

Authors:  Z Dauter; M Dauter; K R Rajashankar
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-02

6.  Purification, characterization and amino acid sequence of a novel enzyme, D-threo-3-hydroxyaspartate dehydratase, from Delftia sp. HT23.

Authors:  Takayuki Maeda; Yuki Takeda; Tomoko Murakami; Atsushi Yokota; Masaru Wada
Journal:  J Biochem       Date:  2010-09-14       Impact factor: 3.387

7.  Effects of threo-beta-hydroxyaspartate derivatives on excitatory amino acid transporters (EAAT4 and EAAT5).

Authors:  Y Shigeri; K Shimamoto; Y Yasuda-Kamatani; R P Seal; N Yumoto; T Nakajima; S G Amara
Journal:  J Neurochem       Date:  2001-10       Impact factor: 5.372

8.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.

Authors:  T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

9.  A novel system for expressing recombinant proteins over a wide temperature range from 4 to 35 degrees C.

Authors:  Nobutaka Nakashima; Tomohiro Tamura
Journal:  Biotechnol Bioeng       Date:  2004-04-20       Impact factor: 4.530

10.  D-Serine dehydratase from chicken kidney: a vertebral homologue of the cryptic enzyme from Burkholderia cepacia.

Authors:  Hiroyuki Tanaka; Atsushi Yamamoto; Tetsuo Ishida; Kihachiro Horiike
Journal:  J Biochem       Date:  2007-10-30       Impact factor: 3.387

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.